Significance of Pharmacoepidemiology and Economics

To review precepts of and practical examples for pharmacoepidemiology and pharmacoeconomics. emphasizes that, in line with healthcare goals for individual patients, rational drug therapy within large, integrated health systems requires evaluating clinical options at both the individual and population levels. Pharmacoepidemiology and pharmacoeconomics are key tools in performing such analyses. Pharmacoepidemiology helps determine the distribution of diseases and the effects of medications—both positive and negative—on patient populations. Pharmacoeconomics then builds on this data, providing methods to assign economic and quality-of-life value to these drug exposures. Together, these fields allow for a comprehensive evaluation of drug therapies, ensuring that both clinical outcomes and resource allocation are optimized.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-10
DOI
https://doi.org/10.5281/zenodo.14845095
Primary Topic
Renal and Vascular Pathologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Significance of Pharmacoepidemiology and Economics

Zenodo (CERN European Organization for Nuclear Research)
Renal and Vascular Pathologies
article

Significance of Pharmacoepidemiology and Economics

article en

Abstract

To review precepts of and practical examples for pharmacoepidemiology and pharmacoeconomics. emphasizes that, in line with healthcare goals for individual patients, rational drug therapy within large, integrated health systems requires evaluating clinical options at both the individual and population levels. Pharmacoepidemiology and pharmacoeconomics are key tools in performing such analyses. Pharmacoepidemiology helps determine the distribution of diseases and the effects of medications—both positive and negative—on patient populations. Pharmacoeconomics then builds on this data, providing methods to assign economic and quality-of-life value to these drug exposures. Together, these fields allow for a comprehensive evaluation of drug therapies, ensuring that both clinical outcomes and resource allocation are optimized.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 37%
Renal and Vascular Pathologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.